The artificial creation of human skin, tissue and internal organs may sound like something from the distant future, but much of it is happening right now in research facilities around the g
Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA.
